Published in Nature on October 28, 2010
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Cancer genome landscapes. Science (2013) 25.33
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
Pancreatic cancer. Lancet (2004) 11.63
The life history of 21 breast cancers. Cell (2012) 10.59
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
EMT and dissemination precede pancreatic tumor formation. Cell (2012) 9.27
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
The causes and consequences of genetic heterogeneity in cancer evolution. Nature (2013) 5.91
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet (2014) 5.74
Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science (2012) 5.50
Tumour heterogeneity and cancer cell plasticity. Nature (2013) 5.47
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol (2011) 4.66
Clonal competition with alternating dominance in multiple myeloma. Blood (2012) 4.39
Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res (2011) 4.33
The lymphatic vasculature in disease. Nat Med (2011) 4.20
Whole genomes redefine the mutational landscape of pancreatic cancer. Nature (2015) 4.01
Tumour heterogeneity in the clinic. Nature (2013) 3.92
The evolutionary history of lethal metastatic prostate cancer. Nature (2015) 3.59
Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (2012) 3.56
Intratumor heterogeneity: evolution through space and time. Cancer Res (2012) 3.45
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell (2014) 3.41
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39
The next-generation sequencing revolution and its impact on genomics. Cell (2013) 3.35
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics (2012) 3.21
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun (2014) 3.12
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature (2014) 2.85
RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet (2014) 2.72
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer (2011) 2.64
Addressing genetic tumor heterogeneity through computationally predictive combination therapy. Cancer Discov (2013) 2.59
EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.59
Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer (2013) 2.56
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell (2014) 2.50
The Pediatric Cancer Genome Project. Nat Genet (2012) 2.49
Origins of metastatic traits. Cancer Cell (2013) 2.49
Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov (2011) 2.49
Genome-wide copy number analysis of single cells. Nat Protoc (2012) 2.47
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nat Genet (2017) 2.42
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012) 2.41
Temporal dissection of tumorigenesis in primary cancers. Cancer Discov (2011) 2.40
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep (2014) 2.27
Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol (2011) 2.11
Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet (2015) 2.10
Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nat Commun (2012) 2.06
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell (2013) 2.00
Evolutionary medicine: its scope, interest and potential. Proc Biol Sci (2012) 1.94
Estimation of rearrangement phylogeny for cancer genomes. Genome Res (2011) 1.91
Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science (2013) 1.90
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas. Cancer Discov (2011) 1.85
Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell (2014) 1.85
Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res (2012) 1.82
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A (2012) 1.82
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLoS One (2014) 1.80
The evolving concept of cancer and metastasis stem cells. J Cell Biol (2012) 1.76
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (2014) 1.74
From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A (2013) 1.71
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol (2014) 1.64
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med (2015) 1.64
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med (2013) 1.63
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev (2013) 1.61
What does physics have to do with cancer? Nat Rev Cancer (2011) 1.59
Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. J Pathol Inform (2012) 1.58
New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol (2012) 1.57
Cancer genome-sequencing study design. Nat Rev Genet (2013) 1.55
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. Sci Transl Med (2015) 1.52
Telomere dysfunction and chromosome instability. Mutat Res (2011) 1.51
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov (2015) 1.51
Chromothripsis and Kataegis Induced by Telomere Crisis. Cell (2015) 1.49
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun (2015) 1.49
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature (2014) 1.49
Mre11-Sae2 and RPA Collaborate to Prevent Palindromic Gene Amplification. Mol Cell (2015) 1.48
Tumor immunosurveillance in human cancers. Cancer Metastasis Rev (2011) 1.48
Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A (2011) 1.47
Uncovering the genomic heterogeneity of multifocal breast cancer. J Pathol (2015) 1.47
Selection and adaptation during metastatic cancer progression. Nature (2013) 1.46
A system-level pathway-phenotype association analysis using synthetic feature random forest. Genet Epidemiol (2014) 1.46
MicroRNA expression characterizes oligometastasis(es). PLoS One (2011) 1.45
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol (2014) 1.44
Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther (2013) 1.43
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia (2014) 1.43
NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget (2011) 1.42
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun (2014) 1.42
From human genome to cancer genome: the first decade. Genome Res (2013) 1.42
Links between mutant p53 and genomic instability. J Cell Biochem (2012) 1.41
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes. J Pathol (2012) 1.41
Drug resistance in cancer: an overview. Cancers (Basel) (2014) 1.39
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res (2012) 1.37
Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study. PLoS Biol (2014) 1.34
Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res (2012) 1.33
Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics (2011) 1.33
Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res (2008) 157.44
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
The Stability of Broken Ends of Chromosomes in Zea Mays. Genetics (1941) 16.95
A large genome center's improvements to the Illumina sequencing system. Nat Methods (2008) 15.56
Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature (2009) 13.45
Pancreatic cancer biology and genetics. Nat Rev Cancer (2002) 7.36
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A (2008) 7.22
Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res (2007) 6.91
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61
Genetic determinants of cancer metastasis. Nat Rev Genet (2007) 6.38
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature (2007) 5.65
Parallel progression of primary tumours and metastases. Nat Rev Cancer (2009) 5.55
Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature (2010) 5.02
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 4.02
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet (2002) 3.45
Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther (2005) 3.28
Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell (2002) 3.06
Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A (2001) 2.91
Replication licensing and cancer--a fatal entanglement? Nat Rev Cancer (2008) 2.86
Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene (2007) 2.14
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A (2008) 1.92
Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther (2008) 1.51
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas. J Gastrointest Surg (2008) 1.23
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
The cancer genome. Nature (2009) 23.13
Signatures of mutational processes in human cancer. Nature (2013) 21.63
International network of cancer genome projects. Nature (2010) 20.35
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science (2009) 18.40
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
A large genome center's improvements to the Illumina sequencing system. Nat Methods (2008) 15.56
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature (2010) 14.50